Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populations

Objectives: We evaluated the importance of ethnicity and pharmacogenetic variations in determining efavirenz pharmacokinetics, auto-induction and immunological outcomes in two African populations. Methods: ART naïve HIV patients from Ethiopia (n = 285) and Tanzania (n = 209) were prospectively enro...

Full description

Saved in:
Bibliographic Details
Main Authors: Ngaimisi, Eliford (Author) , Habtewold, Abiy (Author) , Minzi, Omary (Author) , Makonnen, Eyasu (Author) , Mugusi, Sabina (Author) , Amogne, Wondwossen (Author) , Yimer, Getnet (Author) , Riedel, Klaus-Dieter (Author) , Janabi, Mohammed (Author) , Aderaye, Getachew (Author) , Mugusi, Ferdinand (Author) , Bertilsson, Leif (Author) , Aklillu, Eleni (Author) , Burhenne, Jürgen (Author)
Format: Article (Journal)
Language:English
Published: July 5, 2013
In: PLOS ONE
Year: 2013, Volume: 8, Issue: 7, Pages: 1-13
ISSN:1932-6203
DOI:10.1371/journal.pone.0067946
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1371/journal.pone.0067946
Verlag, lizenzpflichtig, Volltext: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0067946
Get full text
Author Notes:Eliford Ngaimisi, Abiy Habtewold, Omary Minzi, Eyasu Makonnen, Sabina Mugusi, Wondwossen Amogne, Getnet Yimer, Klaus-Dieter Riedel, Mohammed Janabi, Getachew Aderaye, Ferdinand Mugusi, Leif Bertilsson, Eleni Aklillu, Juergen Burhenne

MARC

LEADER 00000caa a2200000 c 4500
001 1778211321
003 DE-627
005 20230426075246.0
007 cr uuu---uuuuu
008 211122s2013 xx |||||o 00| ||eng c
024 7 |a 10.1371/journal.pone.0067946  |2 doi 
035 |a (DE-627)1778211321 
035 |a (DE-599)KXP1778211321 
035 |a (OCoLC)1341423790 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ngaimisi, Eliford  |e VerfasserIn  |0 (DE-588)1197814523  |0 (DE-627)1679539558  |4 aut 
245 1 0 |a Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes  |b a parallel-group prospective cohort study in two sub-Saharan Africa populations  |c Eliford Ngaimisi, Abiy Habtewold, Omary Minzi, Eyasu Makonnen, Sabina Mugusi, Wondwossen Amogne, Getnet Yimer, Klaus-Dieter Riedel, Mohammed Janabi, Getachew Aderaye, Ferdinand Mugusi, Leif Bertilsson, Eleni Aklillu, Juergen Burhenne 
264 1 |c July 5, 2013 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.11.2021 
520 |a Objectives: We evaluated the importance of ethnicity and pharmacogenetic variations in determining efavirenz pharmacokinetics, auto-induction and immunological outcomes in two African populations. Methods: ART naïve HIV patients from Ethiopia (n = 285) and Tanzania (n = 209) were prospectively enrolled in parallel to start efavirenz based HAART. CD4+ cell counts were determined at baseline, 12, 24 and 48 weeks. Plasma and intracellular efavirenz and 8-hydroxyefvairenz concentrations were determined at week 4 and 16. Genotyping for common functional CYP2B6, CYP3A5, ABCB1, UGT2B7 and SLCO1B1 variant alleles were done. Result: Patient country, CYP2B6*6 and ABCB1 c.4036A>G (rs3842A>G) genotype were significant predictors of plasma and intracellular efavirenz concentration. CYP2B6*6 and ABCB1 c.4036A>G (rs3842) genotype were significantly associated with higher plasma efavirenz concentration and their allele frequencies were significantly higher in Tanzanians than Ethiopians. Tanzanians displayed significantly higher efavirenz plasma concentration at week 4 (p<0.0002) and week 16 (p = 0.006) compared to Ethiopians. Efavirenz plasma concentrations remained significantly higher in Tanzanians even after controlling for the effect of CYP2B6*6 and ABCB1 c.4036A>G genotype. Within country analyses indicated a significant decrease in the mean plasma efavirenz concentration by week 16 compared to week 4 in Tanzanians (p = 0.006), whereas no significant differences in plasma concentration over time was observed in Ethiopians (p = 0.84). Intracellular efavirenz concentration and patient country were significant predictors of CD4 gain during HAART. Conclusion: We report substantial differences in efavirenz pharmacokinetics, extent of auto-induction and immunologic recovery between Ethiopian and Tanzanian HIV patients, partly but not solely, due to pharmacogenetic variations. The observed inter-ethnic variations in efavirenz plasma exposure may possibly result in varying clinical treatment outcome or adverse event profiles between populations. 
650 4 |a Africa 
650 4 |a African people 
650 4 |a Alleles 
650 4 |a Antiretroviral therapy 
650 4 |a Highly-active antiretroviral therapy 
650 4 |a HIV 
650 4 |a Pharmacokinetics 
650 4 |a Population genetics 
700 1 |a Habtewold, Abiy  |e VerfasserIn  |4 aut 
700 1 |a Minzi, Omary  |e VerfasserIn  |4 aut 
700 1 |a Makonnen, Eyasu  |e VerfasserIn  |4 aut 
700 1 |a Mugusi, Sabina  |e VerfasserIn  |4 aut 
700 1 |a Amogne, Wondwossen  |e VerfasserIn  |4 aut 
700 1 |a Yimer, Getnet  |e VerfasserIn  |4 aut 
700 1 |a Riedel, Klaus-Dieter  |e VerfasserIn  |0 (DE-588)1034229605  |0 (DE-627)745128432  |0 (DE-576)381859460  |4 aut 
700 1 |a Janabi, Mohammed  |e VerfasserIn  |4 aut 
700 1 |a Aderaye, Getachew  |e VerfasserIn  |4 aut 
700 1 |a Mugusi, Ferdinand  |e VerfasserIn  |4 aut 
700 1 |a Bertilsson, Leif  |e VerfasserIn  |4 aut 
700 1 |a Aklillu, Eleni  |e VerfasserIn  |4 aut 
700 1 |a Burhenne, Jürgen  |d 1963-  |e VerfasserIn  |0 (DE-588)1034228889  |0 (DE-627)745126987  |0 (DE-576)381858197  |4 aut 
773 0 8 |i Enthalten in  |t PLOS ONE  |d San Francisco, California, US : PLOS, 2006  |g 8(2013), 7, Artikel-ID e67946, Seite 1-13  |h Online-Ressource  |w (DE-627)523574592  |w (DE-600)2267670-3  |w (DE-576)281331979  |x 1932-6203  |7 nnas  |a Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes a parallel-group prospective cohort study in two sub-Saharan Africa populations 
773 1 8 |g volume:8  |g year:2013  |g number:7  |g elocationid:e67946  |g pages:1-13  |g extent:13  |a Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes a parallel-group prospective cohort study in two sub-Saharan Africa populations 
856 4 0 |u https://doi.org/10.1371/journal.pone.0067946  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0067946  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211122 
993 |a Article 
994 |a 2013 
998 |g 1034228889  |a Burhenne, Jürgen  |m 1034228889:Burhenne, Jürgen  |d 910000  |d 910100  |e 910000PB1034228889  |e 910100PB1034228889  |k 0/910000/  |k 1/910000/910100/  |p 14  |y j 
999 |a KXP-PPN1778211321  |e 4004539234 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Eliford Ngaimisi, Abiy Habtewold, Omary Minzi, Eyasu Makonnen, Sabina Mugusi, Wondwossen Amogne, Getnet Yimer, Klaus-Dieter Riedel, Mohammed Janabi, Getachew Aderaye, Ferdinand Mugusi, Leif Bertilsson, Eleni Aklillu, Juergen Burhenne"]},"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"July 5, 2013"}],"id":{"doi":["10.1371/journal.pone.0067946"],"eki":["1778211321"]},"physDesc":[{"extent":"13 S."}],"relHost":[{"title":[{"title":"PLOS ONE","title_sort":"PLOS ONE"}],"part":{"text":"8(2013), 7, Artikel-ID e67946, Seite 1-13","volume":"8","extent":"13","year":"2013","pages":"1-13","issue":"7"},"pubHistory":["1.2006 -"],"recId":"523574592","corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"Public Library of Science"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes a parallel-group prospective cohort study in two sub-Saharan Africa populationsPLOS ONE","note":["Schreibweise des Titels bis 2012: PLoS ONE","Gesehen am 20.03.19"],"id":{"eki":["523574592"],"zdb":["2267670-3"],"issn":["1932-6203"]},"origin":[{"publisherPlace":"San Francisco, California, US ; Lawrence, Kan.","dateIssuedDisp":"2006-","dateIssuedKey":"2006","publisher":"PLOS ; PLoS"}],"name":{"displayForm":["Public Library of Science"]},"physDesc":[{"extent":"Online-Ressource"}]}],"person":[{"given":"Eliford","family":"Ngaimisi","role":"aut","display":"Ngaimisi, Eliford","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Habtewold, Abiy","given":"Abiy","family":"Habtewold"},{"role":"aut","display":"Minzi, Omary","roleDisplay":"VerfasserIn","given":"Omary","family":"Minzi"},{"family":"Makonnen","given":"Eyasu","roleDisplay":"VerfasserIn","display":"Makonnen, Eyasu","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Mugusi, Sabina","given":"Sabina","family":"Mugusi"},{"given":"Wondwossen","family":"Amogne","role":"aut","display":"Amogne, Wondwossen","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Yimer, Getnet","given":"Getnet","family":"Yimer"},{"role":"aut","display":"Riedel, Klaus-Dieter","roleDisplay":"VerfasserIn","given":"Klaus-Dieter","family":"Riedel"},{"given":"Mohammed","family":"Janabi","role":"aut","roleDisplay":"VerfasserIn","display":"Janabi, Mohammed"},{"given":"Getachew","family":"Aderaye","role":"aut","display":"Aderaye, Getachew","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Mugusi, Ferdinand","given":"Ferdinand","family":"Mugusi"},{"given":"Leif","family":"Bertilsson","role":"aut","roleDisplay":"VerfasserIn","display":"Bertilsson, Leif"},{"family":"Aklillu","given":"Eleni","roleDisplay":"VerfasserIn","display":"Aklillu, Eleni","role":"aut"},{"role":"aut","display":"Burhenne, Jürgen","roleDisplay":"VerfasserIn","given":"Jürgen","family":"Burhenne"}],"title":[{"subtitle":"a parallel-group prospective cohort study in two sub-Saharan Africa populations","title":"Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes","title_sort":"Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 22.11.2021"],"language":["eng"],"recId":"1778211321"} 
SRT |a NGAIMISIELIMPORTANCE5201